Back to the main directory
EarningsReview / Equity
- Hexagon AB (Buy, TP: SEK540.00) - HexaGONE up to BUY by DnB Markets
- A brake on RWAs - can it hold? by BNP Paribas Exane
- MPC: 3Q Recap: All Eyes on Analyst Day Update; Trimming Estimates, TP to $106 by Raymond James
- KDDI (Buy): Q2 18 results - defending price; Rakuten roaming by New Street Research
- S: Maintain Outperform but Decrease Price Target to $7 by Raymond James
- SPOT: Doing What They Said They Would - Investing for Growth; Strong Buy by Raymond James
- LEVL: Maintain Outperform and $32 Target Price Following 3Q Results by Raymond James
- CODI: Growth Stalled Through 2018, Expect 2019 Tailwinds; Reit. MO2 & TP to $18 by Raymond James
- TEVA: 3Q18: No Big Nasties in U.S. Generics Enables Further EBITDA Muddling Along by Raymond James
- MBIN: Maintain Outperform but Lowering Target Price to $27 for Valuation Reset by Raymond James
- MUSA: 3Q Earnings Below Expectations; Maintain Market Perform by Raymond James
- ARW: Strong 3Q Results; Improved Cash Flow; Maintain Strong Buy by Raymond James
- TFX: 3Q Financial Analysis and Updated Model by Raymond James
- NSP: Healthcare Costs Tracking Better Than Expected; Unit Growth Remains Solid by Raymond James
- GEL: Solid 3Q18; Increasing 2018-19 Estimates with Onshore Growth; TP $27 by Raymond James
- MMP: 3Q Recap: Robust Growth Outlook Drives Story; Reit. MO2, TP at $76 by Raymond James
- MPLX: 3Q18 Recap: Another Beat, Growth Outlook Stout; Raising Estimates, TP $45 by Raymond James
- CACI: Keep Your CACIs On - The Print Doesn’t Match The Trading by Raymond James
- IDXX: Expecting a Cheetah and Getting a Greyhound; Growth Still Strong, But a Touch Slower in 2019 by Raymond James
- WMB: 3Q18 Recap: More Conviction in Growth Runway; Valuation Should Follow by Raymond James
- RDC: ARO Keeps the Jackups Working, Now We Await the Merger by Raymond James
- XPO: 3Q a Tad Soft; Management Changes Topical but FCF Too Strong to Ignore by Raymond James
- AAPL: FX Headwinds; No Longer Disclosing Unit Sales by Raymond James
- BNFT: 2019 Guidance Well Above Consensus; Ride the Re-Rating; Stay Outperform by Raymond James
- Oriflame (Buy, TP: SEK317.00) - Attractive volatility, QTD risk by DnB Markets